May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
One Year Results of Epithelial Laser in situ Keratomileusis (epi-LASIK) in Patients With High Myopia
Author Affiliations & Notes
  • P. M. Prahs
    Ophthalmology, University of Regensburg, Regensburg, Germany
  • W. Herrmann
    Ophthalmology, University of Regensburg, Regensburg, Germany
  • K. Hufendiek
    Ophthalmology, University of Regensburg, Regensburg, Germany
  • H. Helbig
    Ophthalmology, University of Regensburg, Regensburg, Germany
  • Footnotes
    Commercial Relationships  P.M. Prahs, None; W. Herrmann, None; K. Hufendiek, None; H. Helbig, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 2908. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      P. M. Prahs, W. Herrmann, K. Hufendiek, H. Helbig; One Year Results of Epithelial Laser in situ Keratomileusis (epi-LASIK) in Patients With High Myopia. Invest. Ophthalmol. Vis. Sci. 2008;49(13):2908.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate the clinical results of epithelial laser in situ keratomileusis (epi-LASIK) in patients with high myopia and myopic astigmatism with a spherical equivalent of -6 to -8.0 dpt.

Methods: : Retrospective case series of 107 eyes of 62 myopic patients (mean age 33.0 yrs +/- 10.6 [SD]) with a spherical equivalent of -6 to -8 dpt (mean -6.7 dpt +/- 0.7 [SD]) and myopic astigmatism of up to 2 dpt underwent epi-LASIK treatment. After creation of the epithelial flap (EpiVision Microkeratome, Gebauer, Neuhausen, Germany), excimer laser ablation was performed with an Allegretto Wave Eye Q excimer laser system (Wavelight, Erlangen, Germany) applying a wavefront optimized ablation profile. The epithelial flap was repositioned and protected by a soft bandage contact lens (PureVision, Bausch&Lomb, Rochester, NY) for 3 days. No eye was treated with Mitomycin C. Parameters evaluated were Snellen uncorrected and best spectacle corrected visual acuity, manifest refraction and haze grade at baseline and follow-up visits after 1, 3, 6 and 12 months.

Results: : After 1, 3, 6 and 12 months manifest refraction showed a mean spherical equivalent of +0.43 dpt +/- 0.8 [SD], +0.48 dpt +/- 0.5 [SD], +0.27 dpt +/- 0.7 [SD] and +0.05 dpt +/- 0.6 [SD] respectively. After 1 year 75% of the eyes were within +/- 0.5 dpt of the attempted correction, 96% within 1 dpt. 49% gained one or more lines of BSCVA. No eye lost more than one line of BSCVA. Postoperative haze requiring treatment was not observed in any patient, clinically insignificant trace haze was seen in 17% of all corneas.

Conclusions: : Clinical results after epithelial laser in situ keratomileusis indicate that it is safe and effective in the correction of myopia and myopic astigmatism with a spherical equvivalent of up to -8.0 dpt.

Keywords: laser • refractive surgery • cornea: clinical science 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×